Plasminogen activator inhibitor-1 and Restenosis

被引：9
|
作者：
Garg, Nadish
Fay, William P.
机构：
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO USA
[2] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO USA
[3] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA
来源：
CURRENT DRUG TARGETS | 2007年 / 8卷 / 09期
关键词：
D O I：
10.2174/138945007781662355
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Despite the introduction of drug-eluting stents; restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
引用
收藏
页码：1003 / 1006
页数：4
相关论文
共 50 条
  • [41] Plasminogen activator inhibitor-1 in kidney pathology (Review)
    Malgorzewicz, Sylwia
    Skrzypczak-Jankun, Ewa
    Jankun, Jerzy
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (03) : 503 - 510
  • [42] Plasminogen activator inhibitor-1 in patients with ischemic stroke
    Haapaniemi, E
    Tatlisumak, T
    Soinne, L
    Syrjälä, M
    Kaste, M
    [J]. BRAIN EDEMA XI, 2000, 76 : 277 - 278
  • [43] Angiotensin as inducer of plasminogen activator inhibitor-1 and fibrosis
    Ma, LJ
    Fogo, AB
    [J]. RENIN-ANGIOTENSIN SYSTEM AND PROGRESSION OF RENAL DISEASES, 2001, 135 : 161 - 170
  • [44] Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence
    Vaughan, Douglas E.
    Rai, Rahul
    Khan, Sadiya S.
    Eren, Mesut
    Ghosh, Asish K.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (08) : 1446 - 1452
  • [45] The importance of helix F in plasminogen activator inhibitor-1
    Vleugels, N
    Gils, A
    Bijnens, AP
    Knockaert, I
    Declerck, PJ
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 25 - 25
  • [46] The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis
    Glueck, CJ
    Fontaine, RN
    Gruppo, R
    Stroop, D
    Sieve-Smith, L
    Tracy, T
    Wang, P
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (366) : 133 - 146
  • [47] Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents
    Katsaros, K. M.
    Speidl, W. S. .
    Kastl, S. P.
    Zorn, G.
    Huber, K.
    Maurer, G.
    Glogar, D.
    Wojta, J. .
    Christ, G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (03) : 508 - 513
  • [48] PLASMINOGEN ACTIVATOR INHIBITOR-1 PLASMA LEVELS ARE ASSOCIATED WITH CORONARY INSTENT RESTENOSIS OF DRUG ELUTING STENTS
    Katsaros, K.
    Speidl, W.
    Zorn, G.
    Huber, K.
    Maurer, G.
    Glogar, D.
    Wojta, J.
    Christ, G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 161 - 161
  • [49] Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis
    Strauss, BH
    Lau, HK
    Bowman, KA
    Sparkes, J
    Chisholm, RJ
    Garvey, MB
    Fenkell, LL
    Natarajan, MK
    Singh, I
    Teitel, JM
    [J]. CIRCULATION, 1999, 100 (15) : 1616 - 1622
  • [50] Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis
    Ikeda, U
    Hojo, Y
    Shimada, K
    [J]. CIRCULATION, 2000, 102 (20) : E167 - E167
12345